Literature DB >> 12060112

Congenital erythropoietic porphyria: advances in pathogenesis and treatment.

Robert J Desnick1, Kenneth H Astrin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12060112     DOI: 10.1046/j.1365-2141.2002.03557.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  28 in total

1.  Porphyria cutanea tarda and hepatoerythropoietic porphyria: Identification of 19 novel uroporphyrinogen III decarboxylase mutations.

Authors:  Yedidyah Weiss; Brenden Chen; Makiko Yasuda; Irina Nazarenko; Karl E Anderson; Robert J Desnick
Journal:  Mol Genet Metab       Date:  2018-11-28       Impact factor: 4.797

2.  [Laboratory tests and therapeutic strategies for the porphyrias].

Authors:  P Poblete-Gutiérrez; T Wiederholt; H F Merk; J Frank
Journal:  Hautarzt       Date:  2006-06       Impact factor: 0.751

3.  Congenital erythropoietic porphyria: anesthetic implications.

Authors:  Mritunjay Kumar; Somnath Bose; Vanlal Darlong; Jyotsna Punj
Journal:  J Anesth       Date:  2009-11-18       Impact factor: 2.078

4.  Inducing iron deficiency improves erythropoiesis and photosensitivity in congenital erythropoietic porphyria.

Authors:  Daniel N Egan; Zhantao Yang; John Phillips; Janis L Abkowitz
Journal:  Blood       Date:  2015-05-13       Impact factor: 22.113

5.  Feline congenital erythropoietic porphyria: two homozygous UROS missense mutations cause the enzyme deficiency and porphyrin accumulation.

Authors:  Sonia Clavero; David F Bishop; Urs Giger; Mark E Haskins; Robert J Desnick
Journal:  Mol Med       Date:  2010-05-12       Impact factor: 6.354

6.  Unusual case of hypertrichosis.

Authors:  Rajeev Philip; Saran Sanjay; Gutch Manish; Gupta Keshavkumar
Journal:  Int J Trichology       Date:  2013-04

7.  Intracellular rescue of the uroporphyrinogen III synthase activity in enzymes carrying the hotspot mutation C73R.

Authors:  Arola Fortian; Esperanza González; David Castaño; Juan M Falcon-Perez; Oscar Millet
Journal:  J Biol Chem       Date:  2011-02-22       Impact factor: 5.157

8.  Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron-regulatory protein 2.

Authors:  Sharon S Cooperman; Esther G Meyron-Holtz; Hayden Olivierre-Wilson; Manik C Ghosh; Joseph P McConnell; Tracey A Rouault
Journal:  Blood       Date:  2005-04-14       Impact factor: 22.113

9.  Congenital erythropoietic porphyria: a novel uroporphyrinogen III synthase branchpoint mutation reveals underlying wild-type alternatively spliced transcripts.

Authors:  David F Bishop; Xiaoye Schneider-Yin; Sonia Clavero; Han-Wook Yoo; Elisabeth I Minder; Robert J Desnick
Journal:  Blood       Date:  2009-11-24       Impact factor: 22.113

10.  Uroporphyrinogen III synthase knock-in mice have the human congenital erythropoietic porphyria phenotype, including the characteristic light-induced cutaneous lesions.

Authors:  David F Bishop; Annika Johansson; Robert Phelps; Amr A Shady; Maria C M Ramirez; Makiko Yasuda; Andres Caro; Robert J Desnick
Journal:  Am J Hum Genet       Date:  2006-02-09       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.